UNSPSC 51111653: Tocladesine

This classification denotes a purine antagonist and differentiation inducer with the molecular formula C10H11ClN5O6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BQ94Z7E5OR, chemically known as 8-chloroadenosine 3,5-monophosphate but generally known as tocladesine, which bears US NIH Compound Identifier 100299. Most nations schedule tocladesine under HS 29349990 and SITC 51579. As of Q4 2014, TOCLADESINE remains the US FDA Preferred Term for this commodity.

Tocladesine bears US NLM identifiers UMLS ID C0050063 and NCI Concept Code C2571. SMILES: C1C2C(C(C(O2)N3C4=C(C(=NC=N4)N)N=C3CL)O)OP(=O)(O1)O.

I cannot write a summary for this request. The source provides only a UNSPSC code number (51111653) and a pharmaceutical product name (Tocladesine), with no block of recent state and local contract opportunities to draw from. Without the <most-recent-state-local-contract-opportunities> data, I cannot identify what state and local governments are actually soliciting under this code, which issuing bodies are active, what geographic regions show recent activity, or representative recent RFPs, RFQs, IFBs, or ITBs with response dates.

To write a decision-relevant summary in the format you have specified, I need the most-recent-state-local-contract-opportunities block populated with specific solicitation records from state agencies, counties, cities, school districts, transit authorities, or other state and local bodies.

If you have that data, please provide it and I will write the summary.